A point-of-care malaria drug resistance assay (UC Berkeley)

Facebook
Twitter
LinkedIn

BI Filler Photo-01We propose to develop a palm-sized microfluidic device which permits culturing of malaria-infected red blood cells under physiological conditions in suspension. The extent of parasitemia is determined by a label-free magneto-optic technique. Such a device will enable point-of-care antibiotic resistance assays for testing different malarial strains primarily targeting countries in the developing world.

More Winners

PillPal (UC Berkeley)

PillPal is a simple application that integrates drug prices with a patient’s particular health insurance benefits to calculate a patient’s out-of- pocket costs. The application

Read More »

© 2021 Blum Center for Developing Economies

Design by Joseph Kim